Interventional Software for Multi-immunotherapy of Solid Tumors

This study tests specialised software that guides multiple immunotherapy drugs simultaneously for patients with solid tumors. The software helps doctors decide which combinations of immune-boosting treatments to use based on each patient's tumor profile. **You may be eligible if...** - You are over 18 with a confirmed cancer diagnosis and estimated survival of more than 3 months - Your liver function and blood counts are adequate - You have at least one measurable tumor on imaging **You may NOT be eligible if...** - You have previously participated in a clinical trial or received immunotherapy for this cancer - Your liver function is severely impaired (Child-Pugh class C) - Your blood counts or organ function fall below required thresholds Talk to your doctor to see if this trial is right for you.